Skip to main content
Year archive

N4 PHARMA PLC — 2018 filings

All 131 regulatory filings released by N4 PHARMA PLC (N4P) in 2018, sourced directly from the official regulator.

131 Filings
2018 Period
2018 filings (131)
Filing Released Lang
Nuvec licence extension
Regulatory Filings
2018-12-20 English
Share option exercise and issue of equity
Share Issue/Capital Change
2018-12-19 English
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
Interim Results
Interim / Quarterly Report H1 2018
2018-12-12 English
Nominated Adviser Status
Board/Management Information
2018-12-10 English
Poster Presentation of SFX-01 and Trial Update
Regulatory Filings
2018-12-04 English
Notification of Half Year Results
Report Publication Announcement
2018-12-03 English
Nuvec® research update
Regulatory Filings
2018-11-28 English
Investor Presentation in Manchester
Regulatory Filings
2018-11-19 English
Nuvec resource changes
Board/Management Information
2018-11-16 English
Filing of further Nuvec® patent application
Investor Presentation
2018-11-15 English
Second Price Monitoring Extn
Regulatory Filings
2018-11-14 English
Price Monitoring Extension
Regulatory Filings
2018-11-14 English
Second Price Monitoring Extn
Regulatory Filings
2018-11-14 English
Price Monitoring Extension
Regulatory Filings
2018-11-14 English
Second Price Monitoring Extn
Regulatory Filings
2018-11-08 English
Price Monitoring Extension
Regulatory Filings
2018-11-08 English
Second Price Monitoring Extn
Regulatory Filings
2018-11-08 English
Price Monitoring Extension
Regulatory Filings
2018-11-08 English
Directorate Changes
Board/Management Information
2018-11-08 English
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018
Earnings Release 9M 2018
2018-11-06 English
Second Price Monitoring Extn
Regulatory Filings
2018-11-05 English
Price Monitoring Extension
Regulatory Filings
2018-11-05 English
Price Monitoring Extension
Regulatory Filings
2018-11-05 English
Research collaboration update
Regulatory Filings
2018-11-05 English
Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
Regulatory Filings
2018-10-31 English
Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update
Report Publication Announcement
2018-10-30 English
Nuvec® research update
Environmental & Social Information
2018-10-29 English
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
Earnings Release FY 2018
2018-10-26 English
Holding(s) in Company
Major Shareholding Notification
2018-10-23 English
Research collaboration for novel DNA vaccine
Regulatory Filings
2018-10-02 English
Verona Pharma to Host Investor & Analyst R&D Forum on October 12, 2018
Report Publication Announcement
2018-09-27 English
Grant of options
Director's Dealing
2018-09-26 English
Price Monitoring Extension
Regulatory Filings
2018-09-26 English
Second Price Monitoring Extn
Regulatory Filings
2018-09-24 English
Price Monitoring Extension
Legal Proceedings Report
2018-09-24 English
Second Price Monitoring Extn
Share Issue/Capital Change
2018-09-24 English
Price Monitoring Extension
Regulatory Filings
2018-09-24 English
Acceptance of Nuvec® on EUNCL
Regulatory Filings
2018-09-24 English
Issue of Shares & PDMR Announcement
Share Issue/Capital Change
2018-09-20 English
Investor Symposium
Regulatory Filings
2018-09-18 English
Notice of Investor Symposium
Regulatory Filings
2018-09-11 English
Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
Regulatory Filings
2018-08-01 English
Second Price Monitoring Extn
Regulatory Filings
2018-07-30 English
Price Monitoring Extension
Regulatory Filings
2018-07-30 English
Result of AGM
AGM Information
2018-07-26 English
Verona Pharma plc : Notice of Results
Report Publication Announcement
2018-07-26 English
AGM Statement
AGM Information
2018-07-26 English
Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference
Report Publication Announcement
2018-07-24 English
Holding(s) in Company
Major Shareholding Notification
2018-07-17 English
Second Price Monitoring Extn
Regulatory Filings
2018-07-11 English
Price Monitoring Extension
Regulatory Filings
2018-07-11 English
Grant of share options, issue of equity and TVR
Regulatory Filings
2018-07-10 English
Clinical trials preliminary results
Regulatory Filings
2018-07-09 English
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
Report Publication Announcement
2018-06-29 English
Verona Pharma plc : Result of General Meeting of Shareholders
Declaration of Voting Results & Voting Rights Announcements
2018-06-26 English
Nuvec® Update
Regulatory Filings
2018-06-18 English
Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
Regulatory Filings
2018-06-13 English
Full Year Results
Earnings Release FY 2018
2018-06-13 English
Second Price Monitoring Extn
Regulatory Filings
2018-06-11 English
Price Monitoring Extension
Regulatory Filings
2018-06-11 English
Interim Update on STEM Trial
Legal Proceedings Report
2018-06-11 English
Second Price Monitoring Extn
Regulatory Filings
2018-06-07 English
Price Monitoring Extension
Regulatory Filings
2018-06-07 English
Verona Pharma's Shelf Registration Statement declared effective by SEC
Capital/Financing Update
2018-06-04 English
Verona Pharma plc : Block Listing Update
Report Publication Announcement
2018-05-31 English
Verona Pharma to Present at Upcoming Investor Conferences
Report Publication Announcement
2018-05-30 English
Notification of Preliminary Results
Report Publication Announcement
2018-05-30 English
Verona Pharma Files Shelf Registration Statement with SEC
Proxy Solicitation & Information Statement
2018-05-23 English
Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD
Earnings Release Q2 2018
2018-05-22 English
Price Monitoring Extension
Regulatory Filings
2018-05-15 English
Upcoming Investor Presentations
Regulatory Filings
2018-05-14 English
Verona Pharma plc : Miscellaneous
Investor Presentation
2018-05-09 English
Filing of Patent
Regulatory Filings
2018-05-09 English
Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
Earnings Release Q1 2018
2018-05-08 English
Verona Pharma to Present at Bio€quity Europe 2018
Regulatory Filings
2018-05-04 English
Verona Pharma plc : Result of AGM
AGM Information
2018-05-03 English
Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018
Report Publication Announcement
2018-05-02 English
Grant of further European patent
Regulatory Filings
2018-05-02 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement
2018-04-27 English
Second Price Monitoring Extn
Share Issue/Capital Change
2018-04-26 English
Price Monitoring Extension
Regulatory Filings
2018-04-26 English
Final Results
Annual Report FY 2017
2018-04-25 English
Presentation at World Orphan Drug Congress USA
Regulatory Filings
2018-04-24 English
Commencement of Sildenafil Clinical Trial
Regulatory Filings
2018-04-18 English
Verona Pharma Announces Departure of Chief Medical Officer
Board/Management Information
2018-04-11 English
Price Monitoring Extension
Regulatory Filings
2018-04-09 English
Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
Earnings Release Q1 2018
2018-03-26 English
Research Collaboration with Imperial College
Legal Proceedings Report
2018-03-20 English
Verona Pharma to Present at Upcoming Healthcare Investor Conferences
Report Publication Announcement
2018-03-15 English
Verona Pharma plc: 2017 Annual Report and Accounts and Notice of AGM
Report Publication Announcement
2018-03-09 English
Verona Pharma plc : Grant of Options and RSUs and PDMR Dealings
Remuneration Information
2018-03-09 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-03-09 English
Verona Pharma plc : 1st Quarter Results
Director's Dealing
2018-03-08 English
Holding(s) in Company
Major Shareholding Notification
2018-03-08 English
Nuvec® Update
Regulatory Filings
2018-03-08 English
Exercise of Warrants and Total Voting Rights
Regulatory Filings
2018-03-07 English
Update on Novel Sulforaphane Analogues
Regulatory Filings
2018-03-05 English
Second Price Monitoring Extn
Regulatory Filings
2018-03-02 English
Price Monitoring Extension
Transaction in Own Shares
2018-03-02 English
Change of Adviser
Regulatory Filings
2018-03-02 English
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients
Earnings Release Q1 2018
2018-03-02 English
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017
Report Publication Announcement FY 2017
2018-02-27 English
Exercise of Warrants and Total Voting Rights
Regulatory Filings
2018-02-26 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-21 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-19 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-14 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-13 English
Verona Pharma Provides Clinical Development Update
Earnings Release Q1 2018
2018-02-13 English
Second Price Monitoring Extn
Regulatory Filings
2018-02-12 English
Price Monitoring Extension
Regulatory Filings
2018-02-12 English
Second Price Monitoring Extn
Regulatory Filings
2018-02-12 English
Price Monitoring Extension
Regulatory Filings
2018-02-12 English
Holding(s) in Company
Major Shareholding Notification
2018-02-08 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-08 English
Issue of Equity and Director/PDMR Shareholding
Director's Dealing
2018-02-05 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-02-02 English
Award of Grant and Collaboration with MedImmune UK
Regulatory Filings
2018-02-02 English
Exercise of Warrants and Total Voting Rights
Regulatory Filings
2018-01-30 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-01-24 English
Global Business Accelerator Programme in Japan
Regulatory Filings
2018-01-24 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-01-22 English
Holding(s) in Company
Major Shareholding Notification
2018-01-15 English
Poster Presentation of SFX-01 Mechanistic Data
Regulatory Filings
2018-01-15 English
Notification of Major Interest in Shares
Regulatory Filings
2018-01-10 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2018-01-08 English
Holding(s) in Company
Major Shareholding Notification
2018-01-08 English
Notification of Major Interest in Shares
Major Shareholding Notification
2018-01-05 English
Notification of Major Interest in Shares
Director's Dealing
2018-01-05 English
Total Voting Rights
Regulatory Filings
2018-01-02 English